.Pharmacolibrary.Drugs.ATC.R.R01AX03 .Pharmacolibrary.Drugs.ATC.R.R01AX03| name: | IpratropiumBromide |
| ATC code: | R01AX03 | route: | inhalation |
| n-compartments | 2 |
Ipratropium bromide is a short-acting anticholinergic (muscarinic antagonist) bronchodilator that is used for the management of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and, to a lesser extent, asthma. It is administered via inhalation and is currently an approved medication in many countries.
Pharmacokinetic parameters reported for healthy adult volunteers following single inhalation dose.
Panning, CA, & DeBisschop, M (2003). Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 23(2) 183–189. DOI:10.1592/phco.23.2.183.32082 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12587807
MacGregor, TR, et al., & Wood, CC (2016). Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler. Clinical and translational science 9(2) 105–113. DOI:10.1111/cts.12387 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26945929
Lee, YH, et al., & Noh, GJ (2016). Efficiency of a New Mesh-Type Nebulizer (NE-SM1 NEPLUS) for Intrapulmonary Delivery of Ipratropium Bromide in Surgical Patients. Basic & clinical pharmacology & toxicology 118(4) 313–319. DOI:10.1111/bcpt.12499 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26440415